Wells Fargo’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.1K | Hold |
9,746
| – | – | ﹤0.01% | 5338 |
|
|
2025
Q1 | $14.6K | Hold |
9,746
| – | – | ﹤0.01% | 5334 |
|
|
2024
Q4 | $49K | Hold |
9,746
| – | – | ﹤0.01% | 5000 |
|
|
2024
Q3 | $78.6K | Buy |
9,746
+999
| +11% | +$8.05K | ﹤0.01% | 4754 |
|
|
2024
Q2 | $50.4K | Sell |
8,747
-54
| -0.6% | -$311 | ﹤0.01% | 4924 |
|
|
2024
Q1 | $105K | Buy |
8,801
+1
| +0% | +$12 | ﹤0.01% | 4496 |
|
|
2023
Q4 | $165K | Buy |
8,800
+9
| +0.1% | +$168 | ﹤0.01% | 4195 |
|
|
2023
Q3 | $83.4K | Buy |
8,791
+1
| +0% | +$9 | ﹤0.01% | 4552 |
|
|
2023
Q2 | $126K | Buy |
8,790
+6
| +0.1% | +$86 | ﹤0.01% | 4631 |
|
|
2023
Q1 | $135K | Buy |
8,784
+1
| +0% | +$15 | ﹤0.01% | 4384 |
|
|
2022
Q4 | $118K | Buy |
8,783
+1
| +0% | +$13 | ﹤0.01% | 4172 |
|
|
2022
Q3 | $121K | Buy |
8,782
+1
| +0% | +$14 | ﹤0.01% | 4219 |
|
|
2022
Q2 | $99K | Buy |
8,781
+4
| +0% | +$45 | ﹤0.01% | 4386 |
|
|
2022
Q1 | $117K | Hold |
8,777
| – | – | ﹤0.01% | 4921 |
|
|
2021
Q4 | $155K | Sell |
8,777
-1,000
| -10% | -$17.7K | ﹤0.01% | 5029 |
|
|
2021
Q3 | $310K | Buy |
9,777
+9,240
| +1,721% | +$293K | ﹤0.01% | 4633 |
|
|
2021
Q2 | $47K | Buy |
537
+512
| +2,048% | +$44.8K | ﹤0.01% | 5270 |
|
|
2021
Q1 | $1K | Buy |
25
+2
| +9% | +$80 | ﹤0.01% | 6307 |
|
|
2020
Q4 | $0 | Hold |
23
| – | – | ﹤0.01% | 6099 |
|
|
2020
Q3 | $0 | Buy |
+23
| New | – | ﹤0.01% | 5929 |
|